Notably, membrane-bound NE activity has been shown to be elevated in mice with CF-like lung disease and in patients with CF even before soluble NE activity can be detected, while the anti-protease shield remains intact in early stages of lung disease33,45. Here, ELANE is linked to lung disorder.